<DOC>
	<DOCNO>NCT00004859</DOCNO>
	<brief_summary>This randomized phase III trial study carboplatin , paclitaxel , radiation therapy , thalidomide see well work compare carboplatin , paclitaxel , radiation therapy alone treat patient newly diagnose stage III non-small cell lung cancer . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Thalidomide may stop growth non-small cell lung cancer stop blood flow tumor . It yet know combination chemotherapy plus radiation therapy effective without thalidomide .</brief_summary>
	<brief_title>Carboplatin , Paclitaxel , Radiation Therapy With Without Thalidomide Patients With Stage III Non-small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Compare survival time progression patient stage IIIA IIIB non-small cell lung cancer treat carboplatin , paclitaxel , chemoradiotherapy without thalidomide . II . Evaluate toxicity thalidomide-containing regimen compare response rate two group . III . Determine whether inactivation p16 , Death-associated protein kinase ( DAP-kinase ) , O6-methylguanine-DNA methyltransferase ( MGMT ) gene , tissue-inhibitor metalloproteinase 3 ( TIMP-3 ) gene use predict survival patient treat regimen . IV . Determine whether detection methylation biomarker serum use predict survival patient treat regimen . OUTLINE : This randomize study . Patients stratify accord disease histology ( squamous vs nonsquamous ) , performance status ( 0 vs 1 ) , disease stage ( IIIA v IIIB ) , time randomization ( addition chemoradiotherapy v ) . Patients randomize one two treatment arm . ARM A : Patients receive paclitaxel intravenously ( IV ) 3 hour immediately follow carboplatin IV 15-30 minute day 1 22 . Treatment continue every 22 day absence unacceptable toxicity disease progression . ARM B : Patients receive paclitaxel carboplatin arm A . Patients also receive oral thalidomide oral low-dose aspirin daily begin day 1 24 month absence disease progression . Beginning day 43-50 , patient arm stable respond disease receive chemoradiotherapy comprise paclitaxel IV 1 hour carboplatin IV 15-30 minute weekly 6 week radiotherapy ( RT ) 5 day week 6 week . Arm B patient continue oral thalidomide . Patients follow every 2 month 2 year every 6 month 3 year .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>Histologically confirm newly diagnose nonsmall cell bronchogenic carcinoma Squamous cell Adenocarcinoma Large cell undifferentiated Bronchoalveolar Nonsmall cell carcinoma otherwise state Unresectable stage IIIA Mediastinal lymph node enlargement least 1 cm less 2 cm compute tomography ( CT ) scan must mediastinotomy thoracoscopy rule resectability OR Stage IIIB disease without significant pleural effusion Seen CT scan ( see chest xray ) reaccumulate 1 thoracentesis cytologically negative Metastases contralateral , mediastinal , supraclavicular node allow Bidimensionally measurable evaluable disease 18 ECOG performance status 01 Adequate hematopoietic , hepatic , renal function obtain &lt; =4 week prior registration : Platelet count least 100,000/mm^3 White Blood Cell ( WBC ) count least 4,000/mm^3 OR absolute neutrophil count least 2,000/mm^3 Bilirubin normal Serum glutamic oxaloacetic transaminase ( SGOT ) great 2.5 time upper limit normal Creatinine great 1.5 mg/dL OR creatinine clearance least 60 mL/min Fertile patient must use 2 method effective contraception 4 week prior , , 4 week study therapy Concurrent filgrastim ( GCSF ) allow persistent neutropenia Positive pregnancy test , pregnant nursing Uncontrolled high blood pressure , unstable angina , congestive heart failure , myocardial infarction within prior year Serious cardiac arrhythmia require medication Prior radiotherapy area measurable active tumor Less 5 year since prior chemotherapy Other active malignancy Serious uncontrolled active infection Evidence great grade 1 neuropathy history physical examination History seizure disorder Contraindication daily lowdose ( 81 mg/day ) aspirin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>squamous cell lung cancer</keyword>
	<keyword>large cell lung cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>adenocarcinoma lung</keyword>
	<keyword>adenosquamous cell lung cancer</keyword>
	<keyword>bronchoalveolar cell lung cancer</keyword>
</DOC>